...
首页> 外文期刊>Journal of cardiothoracic and vascular anesthesia >Anesthetic management of patients undergoing transcatheter aortic valve implantation
【24h】

Anesthetic management of patients undergoing transcatheter aortic valve implantation

机译:经导管主动脉瓣植入术患者的麻醉管理

获取原文
获取原文并翻译 | 示例

摘要

Objective To compare 2 anesthetic techniques, general anesthesia or monitored anesthesia care, performed by the same cardiac anesthesiologists for transcatheter aortic valve implantation in the authors' institution. Design A retrospective study. Setting A single specialized cardiac surgery center. Participants Ninety-eight patients with severe aortic valve stenosis and a high logistic EuroSCORE considered not eligible to undergo conventional aortic valve replacement. Intervention General anesthesia or monitored anesthesia care. Measurements and Main Results General anesthesia was used in 57 and monitored anesthesia care in 41 patients. The authors compared the following parameters: Duration of procedure, transfusion requirements, cardiac indices, superior vena cava saturation (ScVO2) before and after the aortic valve implantation, hospital length of stay and 30-day mortality. The only significant differences between the groups concerned were the duration of anesthesia (p0.001) and ScVO2 values. Anesthesia duration was prolonged significantly when general anesthesia was administered, and ScVO2 was significantly higher both before and after the valve implantation in the general anesthesia group. Thirty-day mortality was 5.3% in the general anesthesia group and 4.9% in the monitored anesthesia group. Conclusions It would appear that both anesthetic techniques may be used for patients with a high logistic EuroSCORE undergoing transcatheter aortic valve implantation.
机译:目的比较由同一位心脏麻醉医师在作者所在机构进行的经导管主动脉瓣植入术的两种麻醉技术,即全身麻醉或监护麻醉。设计回顾性研究。设置一个专门的心脏外科手术中心。参与者有严重主动脉瓣狭窄和高逻辑EuroSCORE的98例患者被认为不符合接受常规主动脉瓣置换的条件。干预全麻或监护麻醉护理。测量和主要结果57例患者使用了全身麻醉,并对41例患者进行了麻醉监测。作者比较了以下参数:手术时间,输血要求,心脏指数,主动脉瓣植入前后的上腔静脉饱和度(ScVO2),住院时间和30天死亡率。相关组之间唯一的显着差异是麻醉时间(p <0.001)和ScVO2值。进行全身麻醉后,麻醉持续时间显着延长,而在全身麻醉组中,在瓣膜植入前后,ScVO2明显升高。全身麻醉组30天死亡率为5.3%,监测麻醉组为4.9%。结论似乎两种麻醉技术均可用于高逻辑EuroSCORE接受经导管主动脉瓣膜植入术的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号